Dorsal column stimulation (DCS): cost to benefit analysis

Acta Neurochir Suppl (Wien). 1991;52:121-3. doi: 10.1007/978-3-7091-9160-6_33.

Abstract

In order to analyse the ratio of costs to clinical benefit of the implantation of a neurostimulator (type Medtronic SE-4) we examined a group of 14 patients who required treatment for chronic lumboischialgia after repeated surgery for herniated discs. Over a period of two years we evaluated the pre- and postimplantation costs. The implantation of a DC-Stimulator resulted in a striking decrease in drug requirements, in the total time of clinical treatment, and in the degree of disability. The DCS provides a satisfying method of treatment for chronic lumboischialgia after repeated surgery for herniated discs. Despite relatively high primary costs, treatment with a DCS results in a significant decrease in the accumulated expenses in comparison to other methods of medical treatment in similar cases.

MeSH terms

  • Analgesia, Epidural / instrumentation*
  • Back Pain / economics
  • Back Pain / physiopathology
  • Back Pain / therapy*
  • Cost-Benefit Analysis
  • Electric Stimulation Therapy / economics*
  • Electric Stimulation Therapy / instrumentation*
  • Electrodes, Implanted*
  • Female
  • Ganglia, Spinal / physiopathology*
  • Humans
  • Intervertebral Disc Displacement / surgery
  • Male
  • Postoperative Complications / economics
  • Postoperative Complications / physiopathology
  • Postoperative Complications / therapy
  • Prostheses and Implants / economics*